Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
US pharma tariffs: What they mean for drug prices
US drug tariffs may not hit branded prices hard, but generics and supply chains face disruption. Here’s what pharma leaders need to know.
Read more
Spotlight: January 2024
Take a look at some of the top pharma news stories of the past month including the latest investments, emerging technologies, new facilities and more.
HBA announces 2024 Woman of the Year
Alnylam’s Dr Yvonne Greenstreet is named Woman of the Year by the Healthcare Businesswomen’s Association
Spotlight: December 2023
Take a look at the top pharma news stories of the past month including projections for the years ahead, new investments, pricing negotiations and more.
Spoonful of technology: Oct-Dec 2023
Dive into the top technology stories of the past few months as GOLD explores the funding landscape and the latest innovations in the health tech market
Spotlight: November 2023
GOLD looks back at some of the top pharma news stories of the past month including new appointments, regulatory wins and surprising survey results.
Spotlight: October 2023
Discover the latest updates in the pharma industry, including new regulations, company separations, and healthcare reforms.
Non-opioid pain medication wins FDA approval
FDA approved a new non-opioid medication for patients with post-operative pain who are being treated in hospital. Read more now.
Spotlight: September 2023
GOLD looks back at some of the top news stories from the pharmaceutical industry in the last month, covering opinion polls, landmark approvals and major projects on the horizon
Loading posts...
« Previous
1
…
18
19
20
21
22
…
26
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View